Enterprise Solutions

INSIGHTS ON ENTERPRISE SOLUTIONS

Using Client Centricity As Fuel For Innovative Biologics Development And Manufacturing Solutions
Complex biologics require flexible development, advanced analytics, and quality by design. Learn how collaborative bioprocessing reduces risk, enables efficient scale‑up, and supports clinical success.
Quality By Design Understanding And Securing Virus Clearance
Data-driven virus clearance improves risk assessment, process insight, and study design. Learn how Quality by Design cuts late-stage risk while strengthening regulatory confidence and viral safety.
Tech Transfer Roundtable: Real World Lessons From Rentschler Biopharma's Experts
Real‑world lessons for planning and executing tech transfers, with practical insights on early alignment, process readiness, risk reduction, and cross‑functional coordination for smoother scale‑up.
How Can Bioprocessing Professionals Evolve Their Manufacturing For Greater Flexibility And Efficiency?
Manufacturing flexibility is now a competitive differentiator. Here's how single-use technologies are reshaping bioprocessing facility design, scalability, and sustainability strategy.

3 Innovations For Reducing Risk In Continuous Downstream Bioprocessing
4/21/2026

Batch-to-continuous transitions in downstream bioprocessing carry real risks. Here's how advanced analytics, smarter buffer strategies, and single-use systems are changing that calculus.
Syringe–Cartridge Filling Line In Action
4/21/2026

Designed for medium‑ to high‑volume ISO syringes and cartridges, this high‑speed filling line delivers tight manufacturing control, supports larger batches, and meets growing biologics demand.
Cell Based Potency Assays: De-Risk Your Path With An Experienced CDMO
4/21/2026

Thorough characterization is key to unlocking the potential of antibody-based therapeutics. Leveraging a CDMO's extensive capabilities and expertise can allow you to navigate the biopharmaceutical development landscape.
De-Risk Nucleic Acid Therapeutics Through Strategic Outsourcing
4/20/2026

Bringing a nucleic acid therapy to market requires specialized formulation and development knowledge. Innovators need rigorous analytical and formulation strategies to achieve stability and quality.

Houston, We Have A Complex Biopharma Market! Taking Off With The Right CDMO

Scientific innovation alone isn’t enough. Success requires smart development, adaptable strategies, and partners who manage pressure, supply risk, and tight timelines — while keeping quality central.
Syracuse Bio Campus: Every Detail. Built Around You

The Syracuse Bio Campus offers U.S.-based mammalian production and bioconjugation, supporting development through commercial manufacturing with regulatory expertise and tailored solutions.
Aseptic Fill Finish

One of the few CDMOs offering sterile fill, device manufacturing, and final assembly at one site — combining expertise, scale, and flexibility for clinical, commercial, and niche production.
U.S. Pharmaceutical Tariffs (Section 232): Implications & Actions

New U.S. tariffs are reshaping pharma manufacturing. Early action to assess exposure and pursue onshoring can cut risk, protect margins, and strengthen supply chains.
Scalable Solutions For High Potent OSD Manufacturing

High potent oral solid dose manufacturing demands rigorous containment, scalable processes, and regulatory alignment. Learn how closed systems, advanced facilities, and flexible batch strategies support safe development and reliable commercial supply.